Assessment of myocardial viability by cardiovascular magnetic resonance imaging

European Heart Journal

Volumn 23, Issue 8, 2002, Pages 602-619

  Mahrholdt, H ^a,c   Wagner, A ^b,c   Judd, R M ^c   Sechtem, Udo ^a  

^a ROBERT BOSCH HOSPITAL   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Cardiovascular magnetic resonance imaging; Dobutamine; High energy phosphates; Inotropic reserve; Late contrast enhancement; Viability; Wall thickness

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

CARDIOVASCULAR SYSTEM; CONTRAST ENHANCEMENT; HEART EDEMA; HEART INFARCTION; HEART LEFT VENTRICLE WALL; HEART MUSCLE; HEART MUSCLE ISCHEMIA; HIGH ENERGY PHOSPHATE; HUMAN; IMAGE ANALYSIS; INOTROPISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REVIEW; SIGNAL PROCESSING;

CELL SURVIVAL; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MYOCARDIAL ISCHEMIA; MYOCARDIUM; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036554782     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.2001.3038     Document Type: Review

References (84)

1. Hammermeister KE, de Rouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic, and quantitative angiographic evaluations. Circulation 1979; 59: 421-30.
2. Harris PJ, Harrell FE, Lee KL, Behar VS, Rosati RA. Survival in medically treated coronary artery disease. Circulation 1979; 60: 1259-69.
3. Mock MB, Ringqvist I, Fisher LD et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circulation 1982; 66: 562-8.
4. Nixon JV, Brown CN, Smitherman TC. Identification of transient and persistent segmental wall motion abnormalities in patients with unstable angina by two-dimensional echocardiography. Circulation 1982; 65: 1497-503.
5. Kloner RA, Allen J, Cox TA, Zheng Y, Ruiz CE. Stunned left ventricular myocardium after exercise treadmill testing in coronary artery disease. Am J Cardiol 1991; 68: 329-34.
6. Breisblatt WM, Stein KL, Wolfe CJ et al. Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgery. J Am Coll Cardiol 1990; 15: 1261-9.
7. Touchstone DA, Beller GA, Nygaard TW, Tedesco C, Kaul S. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: A tomographic assessment using two-dimensional echocardiography. J Am Coll Cardiol 1989; 13: 1506-13.
8. Anselmi M, Golia G, Cicoira M. Prognostic value of detection of myocardial viability using low-dose dobutamine echocardiography in infarcted patients. Am J Cardiol 1998; 81: 21G-28G.
9. Picano E, Sicari R, Landi P et al. Prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: A dobutamine stress echocardiographic study. Circulation 1998; 98: 1078-84.
10. Previtali M, Fetiveau R, Lanzarini L, Cavalotti C, Klersy C. Prognostic value of myocardial viability and ischemia detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis. J Am Coll Cardiol 1998; 32: 380-6.
11. Kaul S. There may be more to myocardial viability than meets the eye. Circulation 1995; 92: 2790-3.
12. Gibbons RJ, Miller TD, Christian TF. Infarct size measured by single photon emission computed tomographic imaging with (99m)Tc-sestamibi: A measure of the efficacy of therapy in acute myocardial infarction. Circulation 2000; 101: 101-8.
13. Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc sestamibi imaging predicts subsequent mortality. Circulation 1995; 92: 334-41.
14. Kaul S. Assessing the myocardium after attempted reperfusion: Should we bother? Circulation 1998; 98: 625-7.
15. Yokota C, Nonogi H, Miyazaki S et al. Gadolinium-enhanced magnetic resonance imaging in acute myocardial infarction. Am J Cardiol 1995; 75: 577-81.
16. Adams JED, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is MB creatine kinase the choice for the 1990s? Circulation 1993; 88: 750-63.
17. Fishbein MC, Meerbaum S, Rit J et al. Early phase acute myocardial infarct size quantification: Validation of the triphenyl tetrazolium chloride tissue enzyme staining technique. Am Heart J 1981; 101: 593-600.
18. Heusch G, Schulz R. Hibernating myocardium: A review. J Mol Cell Cardiol 1996; 28: 2359-72.
19. Cigarroa CG, de Filippi CR, Brickner ME, Alvarez LG, Wait MA, Grayburn PA. Dobutamine stress echocardiography identifies hibernating myocardium and predicts recovery of left ventricular function after coronary revascularization. Circulation 1993; 88: 430-6.
20. Baer FM, Voth E, LaRosee K et al. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. Am J Cardiol 1996; 78: 415-19.
21. Pflugfelder PW, Wisenberg G, Prato FS, Carroll SE, Turner KL. Early detection of canine myocardial infarction by magnetic resonance imaging in vivo. Circulation 1985; 71: 587-94.
22. Fieno DS, Kim RJ, Chen EL, Lomasney JW, Klocke FJ, Judd RM. Contrast-enhanced magnetic resonance imaging of myocardium at risk: Distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol 2000; 36: 1985-91.
23. Kim RJ, Fieno DS, Parrish TB et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999; 100: 1992-2002.
24. Saeed M, Wendland MF, Masui T et al. Dual mechanisms for change in myocardial signal intensity by means of a single MR contrast medium - Dependence on concentration and pulse sequence. Radiology 1993; 186: 175-82.
25. Schaeffer S, Malloy CR, Katz J et al. Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium identification of the myocardial bed at risk. J Am Coll Cardiol 1988; 12: 1064-72.
26. Koenig SH, Spiller M, Brown RD 3rd, Wolf GL. Relaxation of water protons in the intra- and extracellular regions of blood containing Gd(DTPA). Magn Reson Med 1986; 3: 791-5.
27. Weinmann HJ, Brasch RC, Press WR, Wesbey GE. Characteristics of gadolinium-DTPA complex: A potential NMR contrast agent. Am J Roentgenol 1984; 142: 619-24.
28. Jennings RB, Schaper J, Hill ML, Steenbergen C, Reimer KA. Effect of reperfusion late in the phase of reversible ischaemic injury. Changes in cell volume, electrolytes, metabolites, and ultrastructure. Circ Res 1985; 56: 262-78.
29. Reimer KA, Jennings RB. Myocardial Ischemia, Hypoxia and Infarction. In: Fozzard HA et al. eds. The Heart and Cardiovascular System. New York, NY: Raven Press, 1992: 1875-1973.
30. Whalen DA, Hamilton DG, Ganote CE, Jennings RB. Effect of a transient period of ischemia on myocardial cells. I. Effects on cell volume regulation. Am J Pathol 1974; 74: 381-97.
31. Ambrosio G, Weisman HF, Mannisi JA, Becker LC. Progressive impairment of regional myocardial perfusion after initial restoration of postischaemic blood flow. Circulation 1989; 80: 1846-61.
32. Kim RJ, Chen EL, Lima JAC, Judd RM. Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. Circulation 1996; 94: 3318-26.
33. Lima JAC, Jeremy R, Guier W et al. Accurate systolic wall thickening by nuclear magnetic resonance imaging with tissue ragging: Correlation with sonomicrometers in normal and ischaemic myocardium. J Am Coll Cardiol 1993; 21: 1741-51.
34. Perrone-Filardi P, Bacharach SL, Dilsizian V et al. Metabolic evidence of viable myocardium in regions with reduced wall thickness and absent wall thickening in patients with chronic ischaemic left ventricular dysfunction. J Am Coll Cardiol 1992; 20: 161-8.
35. Delanghe J, de Buyzere M, de Scheerder I et al. Creatine determinations as an early marker for the diagnosis of acute myocardial infarction. Ann Clin Biochem 1988; 25: 383-8.
36. Ingwall JS, Kramer MF, Fifer MA et al. The creatine kinase system in normal and diseased human myocardium. N Engl J Med 1985; 313: 1050-4.
37. Yabe T, Mitsunami K, Inubushi T, Kinoshita M. Quantitative measurements of cardiac phosphorus metabolites in coronary artery disease by 31P magnetic resonance spectroscopy. Circulation 1995; 92: 15-23.
38. Bottomley PA. MR spectroscopy of the human heart: The status and the challenges. Radiology 1994; 191: 593-612.
39. Bottomley PA, Weiss RG. Non-invasive magnetic-resonance detection of creatine depletion in non-viable infarcted myocardium. Lancet 1998; 351: 714-18.
40. Mallory GK, White PD, Salcedo-Galger J. The speed of healing of myocardial infarction: A study of the pathologic anatomy in 72 cases. Am Heart J 1939; 18: 647-71.
41. Pirolo JS, Hutchins GM, Moore GW. Infarct expansion: Pathologic analysis of 204 patients with a single myocardial infarct. J Am Coll Cardiol 1986; 7: 349-54.
42. Ito H, Maruyama A, Iwakura K et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996; 93: 223-8.
43. Sayad DE, Willett DL, Bridges WH et al. Noninvasive quantitation of left ventricular wall thickening using cine magnetic resonance imaging with myocardial tagging. Am J Cardiol 1995; 76: 985-9.
44. Nagel E, Fleck E. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: Comparison with dobutamine stress echocardiography. Circulation 1999; 99: 763-70.
45. Dendale P, Franken PR, van der Wall EE, de Roos A. Wall thickening at rest and contractile reserve early after myocardial infarction: Correlation with myocardial perfusion and metabolism. Coron Artery Dis 1997; 8: 259-64.
46. Baer FM, Voth E, Schneider CA, Theissen P, Schicha H, Sechtem U. Comparison of low-dose dobutamine-gradientecho magnetic resonance imaging and positron emission tomography with [18F]fluorodeoxyglucose in patients with chronic coronary artery disease. A functional and morphological approach to the detection of residual myocardial viability. Circulation 1995; 91: 1006-15.
47. Baer FM, Smolarz K, Jungehulsing M et al. Chronic myocardial infarction: Assessment of morphology, function, and perfusion by gradient echo magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile SPECT. Am Heart J 1992; 123: 636-45.
48. Garcia DD, Oliveras J, Gili J et al. Analysis of myocardial edema by magnetic resonance imaging early after coronary artery occlusion with or without reperfusion. Cardiovasc Res 1993; 27: 1462-9.
49. Fisher MR, McNamara MT, Higgins CB. Acute myocardial infarction: MR evaluation in 29 patients. Am J Roentgenol 1987; 148: 247-51.
50. Johnston DL, Wendt RE, Mulvagh SL, Rubin H. Characterization of acute myocardial infarction by magnetic resonance imaging. Am J Cardiol 1992; 69: 1291-5.
51. Thompson RC, Liu P, Brady TJ, Okada RD, Johnston DL. Serial magnetic resonance imaging in patients following acute myocardial infarction. Magn Reson Imaging 1991; 9: 155-8.
52. Lim TH, Hong MK, Lee JS et al. Novel application of breath-hold turbo spin-echo T2 MRI for detection of acute myocardial infarction. JMRI 1997; 7: 996-1001.
53. de Roos A, Doornbos J, van der Wall EE, van Voorthuisen AE. MR imaging of acute myocardial infarction: Value of Gd-DTPA. Am J Roentgenol 1988; 150: 531-4.
54. Matheijssen NAA, de Roos A, van der Wall EE et al. Acute myocardial infarction: Comparison of T2-weighted and T1-weighted gadolinium-DTPA enhanced MR imaging. Magn Reson Med 1991; 17: 460-9.
55. van Rugge FP, van der Wall EE, van Dijkman PR, Louwerenburg HW, de Roos A, Bruschke AV. Usefulness of ultrafast magnetic resonance imaging in healed myocardial infarction. Am J Cardiol 1992; 70: 1233-7.
56. Edelman RR, Wallner B, Singer A, Atkinson DJ, Saini S. Segmented turboFLASH: Method for breath-hold MR imaging of the liver with flexible contrast. Radiology 1990; 177: 515-21.
57. Simonetti OP, Kim RJ, Fieno DS et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 2001; 218: 215-23.
58. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet 2001; 357: 21-8.
59. de Roos A, van Rossum AC, van der Wall E et al. Reperfused and nonreperfused myocardial infarction: diagnostic potential of Gd-DTPA - Enhanced MR imaging. Radiology 1989; 172: 717-20.
60. Eichstaedt HW, Felix R, Danne O, Dougherty FC, Schmutzler H. Imaging of acute myocardial infarction by magnetic resonance tomography (MRT) using the paramagnetic relaxation substance gadolinium-DTPA. Cardiovasc Drugs Ther 1989; 3: 779-88.
61. Lima JA, Judd RM, Bazille A, Schulman SP, Atalar E, Zerhouni EA. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. Circulation 1995; 92: 1117-25.
62. van Rossum AC, Visser FC, van Eenige MJ et al. Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis. Am J Cardiol 1990; 65: 845-51.
63. Dendale P, Franken PR, Block P, Pratikakis Y, de Roos A. Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. Am Heart J 1998; 135: 875-80.
64. Kim RJ, Wu E, Rafael A et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000; 343: 1445-53.
65. Wu KC, Zerhouni EA, Judd RM et al. Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation 1998; 97: 765-72.
66. Ito H, Maruyama A, Iwakura K et al. Clinical implications of the 'no reflow' phenomenon. A predictor of complications and left ventricular remodeling in reperfused anterior wall myocardial infarction. Circulation 1996; 93: 223-8.
67. White HD, Norris RM, Brown MA, Brandt PW, Whitlock RM, Wild CJ. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation 1987; 76: 44-51.
68. Saeed M, Lund G, Wendland MF, Bremerich J, Weinmann H, Higgins CB. Magnetic resonance characterization of the peri-infarction zone of reperfused myocardial infarction with necrosis-specific and extracellular nonspecific contrast media. Circulation 2001; 103: 871-6.
69. Kramer CM, Rogers WJ Jr, Mankad S, Theobald TM, Pakstis DL, Hu YL. Contractile reserve and contrast uptake pattern by magnetic resonance imaging and functional recovery after reperfused myocardial infarction. J Am Coll Cardiol 2000; 36: 1835-40.
70. Dubnow MH, Burchell HB, Titus JL. Postinfarction left ventricular aneurysm. A clinicomorphologic and electrocardiographic study of 80 cases. Am Heart J 1965; 70: 753-60.
71. Baer FM, Theissen P, Schneider CA et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. J Am Coll Cardiol 1998; 31: 1040-8.
72. Faletra F, Crivellaro W, Pirelli S et al. Value of transthoracic two-dimensional echocardiography in predicting viability in patients with healed Q-wave anterior wall myocardial infarction. Am J Cardiol 1995; 76: 1002-6.
73. Lawson MA, Johnson LL, Coghlan L et al. Correlation of thallium uptake with left ventricular wall thickness by cine magnetic resonance imaging in patients with acute and healed myocardial infarcts. Am J Cardiol 1997; 80: 434-41.
74. Eichstaedt HW, Felix R, Dougherty FC, Langer M, Rutsch W, Schmutzler H. Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium-DTPA. Clin Cardiol 1986; 9: 527-35.
75. Nishimura T, Kobayashi H, O'hara Y et al. Serial assessment of myocardial infarction by using gated MR imaging and Gd-DTPA. Am J Roentgenol 1989; 153: 715-20.
76. van Dijkman PR, van der Wall EE, de Roos A et al. Acute, subacute, and chronic myocardial infarction: Quantitative analysis of gadolinium-enhanced MR images. Radiology 1991; 180: 147-51.
77. Fedele F, Montesano T, Ferro-Luzzi M et al. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: Role of magnetic resonance imaging. Am Heart J 1994; 128: 484-9.
78. Ramani K, Judd RM, Holly TA et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. Circulation 1998; 98: 2687-94.
79. Bonow RO. Identification of viable myocardium. Circulation 1996; 94: 2674-80.
80. Maes A, Flameng W, Nuyts J et al. Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation 1994; 90: 735-45.
81. Dakik HA, Howell JF, Lawrie GM et al. Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: Correlation with histopathology and postoperative improvement in cardiac function. Circulation 1997; 96: 2892-8.
82. Zamorano J, Delgado J, Almeria C et al. Comparison of low-dose dobutamine echocardiography vs. dobutamine magnetic resonance imaging for assessment of myocardial viability: A functional and morphologic approach. Eur Heart J 1998; 19 (Abstr Suppl): 207.
83. Kim RJ, Lima JA, Chen EL et al. Fast 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. Circulation 1997; 95: 1877-85.
84. Kim RJ, Judd RM, Chen EL, Fieno DS, Parrish TB, Lima JA. Relationship of elevated 23Na magnetic resonance image intensity to infarct size after acute reperfused myocardial infarction. Circulation 1999; 100: 185-92.